Shares on issue are 115m AT 82c = $92m Westpac securities has it...

Shares on issue are 115m AT 82c = $92m

Westpac securities has it at $92m

Why is make cap showing up as $123m on HC

Debate the facts

Agile trial already cost over $7m Australian dollars and yet to commence

Many here are experts on Agile trials and believe that commercialisation can be achieved on minimal patient numbers in minimal timeframes and minimal costs

We were told countless times in past 12 months no more CR;s - yet there have been 2-3 and its only October 2020

Refer Concurrent trials 1-2 years ongoing and still no news or data

When TMZ has been around for decades and tried on tens of thousands varying patients etc

PFS or OS has been measured on n= 30 to date

Each to their own like I stated at $1 or 90c etc well overbought at this point in time


DYOR and not advice only opinion which is closer to reality than fantasy